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Background/Introduction
Endothelial injury during the surgical intervention can
significantly affect the functional status of the vein. The
endothelial layer plays a vital role in the long saphenous
vein for ensuring smooth blood flow and the prevention
of vasoconstriction and thrombi formation within the
blood vessels. There are few histological studies compar-
ing the different vein harvesting techniques that have
studied endothelial layer integrity using CD31 on
human long saphenous veins.
Aims/Objectives
Immunohistochemistry (IHC) remains the gold standard
for studying the morphological status of the vein.
Although previous studies have used IHC markers to
score endothelial integrity, none of them compared the
quality of CD34 staining following CABG surgery, parti-
cularly in terms of colour, intensity and distribution of
their expression. This study aims to compare the
endothelial markers CD31 and CD34 as reliable markers
of endothelial damage on human long saphenous vein.
This is the first study which directly compares these dif-
ferences to identify and set a standard for future IHC on
long saphenous veins.
Method
Patients were consented prior taking part in this study,
which was approved by the Greater Manchester North
East - National Research Ethics Committee (NREC).
Ten tissue samples were obtained from ten traditional
open vein harvesting patients and were automatically
processed and stained using immunohistochemistry for
CD31 and CD34. The colour, intensity and distribution
of the staining on the tissues were scored blindly by five
independent scorers and an expert histopathologist for
this study. None of these collaborators were involved at
any stage of this research project.
Results
Consecutive saphenous vein sections were stained using
anti-CD31 and anti-CD34 antibodies. A significantly dif-
ferent pattern of expression was found in terms of col-
our, intensity and distribution. The CD34 antibody
demonstrated greater colour (p < 0.007), intensity (p <
0.019) and distribution (p < 0.007) compared to CD31.
Discussion/Conclusion
In conclusion, the use of CD34 for assessing the
endothelial integrity is more suitable than CD31. This
study provides novel evidence regarding the use of these
markers which can have important clinical effects, for
example when used for coronary artery bypass surgery.
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